Home (Anticancer Research)
Anticancer Research is an international journal designed to rapidly publish original papers and reviews on experimental and clinical cancer research. Anticancer Research was established in 1981 by J.G. Delinasios. In this site you may find information concerning the editorial board, editorial policy, subscriptions, submission of manuscripts, online open articles, advertising, special offers for authors and a current list of accepted manuscripts.
The Special Issue of Anticancer Research on New Anticancer Agents, Volume 39, No 7, July 2019, pp 3295-3974
has now been published, including 18 reviews, 45 experimental and 19 clinical studies
Now the entire contents of Anticancer Research published from 2013 till today
can be accessed with ease from Android, iPhone, iPad and compatible Chromebook devices.
Special Issue of Anticancer Research
on “New Anticancer Agents” 2020
TOPICS: A. Experimental studies on “New Anticancer Agents”
1. Synthesis and evaluation in vitro and in vivo, 2. Mechanism of action,
3. Reversal of resistance to anticancer agents, 4. Oncolytic viruses
B. Clinical studies on “New Anticancer Agents”
1. Pharmacology, 2. Clinical trials, 3. Combination chemotherapy,
4. Immunotherapeutic agents, 5. New methodologies in drug delivery, 6. Vaccines
Deadline for article submission: June 25, 2020.
Publication: September 2020.
Information: Dr. George J. Delinasios, e-mail: email@example.com
Impact factor (2019): 1.935
Total articles: 888
Total cites: 19,809
Library Recommendation Form
Please print and complete this form. Send or give the completed form to your librarian to recommend Anticancer Research.
|Your link to essential information on cancer research published in the last 40 years.
ANTICANCER RESEARCH USA, Inc.
111 Bay Avenue, Highlands, NJ 07732, USA.
Information – Editorial & Production Office:
Managing Editor: G. J. Delinasios, International Institute of Anticancer Research,
1st km Kapandritiou- Kalamou Rd., P.O.Box 22, Kapandriti, Attiki 19014, Greece.
Tel & Fax : +30-22950-52945, +30-22950-53389